Peptide reference entry
Caution. Still experimental.
Eloralintide is a once-weekly injected amylin receptor agonist designed to reduce appetite and body weight, with early human data showing dose-dependent weight loss. It is being studied on its own and alongside incretin drugs. Regulatory status and long-term outcomes are still being defined in ongoing trials.
Checked Jul 15, 2026.
Stack logs each dose you take, tracks what is left in the vial or bottle and shows how you kept to your plan. It records what you choose and does not recommend anything. Everything stays on your phone, with no account.
Get Stack on Google Play Peptide reconstitution calculatorThis entry summarises published information in plain language. It is not medical advice, a dosing recommendation or a substitute for a qualified healthcare professional. Many peptides are not approved for human use, and legal status varies by country. Check anything you rely on against primary sources.